We launched our Duke Pain Seminar Series for 2026 with Dr. David Pisetsky’s highly educational & insightful presentation on chronic pain in lupus. #Duke_CTPM ⭐️discordance between patient vs clinician evaluation of lupus activity ⭐️nociplasticity as a useful term for lupus pain, fatigue, brain fog

Opioid Addiction Treatment Delivered on the Front Lines “Buprenorphine changes the dynamic,” said Godfrey, “It not only prevents overdose for up to 24 hours, but it also eases withdrawal symptoms, giving us a chance to talk about treatment.” medschool.duke.edu/stories/opio...

Huge thanks to Dr. Anne Baker (first author), @drkenweber.bsky.social , and our brilliant biostatistician Morgan Rosser for helping to get this published!

New paper from my lab in Nature Scientific Reports! Using #spinal cord MRIs, we show 1st evidence of decreased cervical gray matter volume in opioid-using #Fibromyalgia cohort, but with less GMV relating to less #pain severity & interference. #Duke_CTPM Full paper here (free!) 👉🏼 rdcu.be/eywsK

Incredible cutting-edge & emerging research on low intensity focused ultrasound #LIFU of the brain's prelimbic cortex by @WendyLynchUVA and of the insula to reduce nicotine/smoking craving by Mary Lee @DeptVetAffairs #CPDD2025 @cpddorg.bsky.social

Our new paper in Journal of Pain shows similar fibromyalgia pressure pain hypersensitivity among those who take vs do not take opioids. Bonus preliminary finding: Opioids may reduce FM pressure pain sensitivity during the first few hours after a dose is taken. pubmed.ncbi.nlm.nih.gov/40472985/

New #OpenAccess publication from our lab showing #brain differences in regions involved in #attention during a reward task in individuals with #fibromyalgia , with potential influence of pain duration and opioid use. @dukebrain.bsky.social www.nature.com/articles/s41...

Recap of our Pain Neuroimaging Special Interest Group "SIG" meeting at the #USASP2025 Annual Scientific Meeting in Chicago: Fun networking and incredible data blitz speakers!